These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical review of ribavirin. Eggleston M Infect Control; 1987 May; 8(5):215-8. PubMed ID: 3298116 [TBL] [Abstract][Full Text] [Related]
8. Clinical experiences using the antiviral 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in Mexico. Zertuche HF; Perches RD Ann N Y Acad Sci; 1977 Mar; 284():284-8. PubMed ID: 360903 [TBL] [Abstract][Full Text] [Related]
9. Ribavirin: beginning the blitz on respiratory viruses? Hall CB Pediatr Infect Dis; 1985; 4(6):668-71. PubMed ID: 3001662 [No Abstract] [Full Text] [Related]
10. Ribavirin and inosiplex: a review of their present status in viral diseases. Chang TW; Heel RC Drugs; 1981 Aug; 22(2):111-28. PubMed ID: 6167418 [TBL] [Abstract][Full Text] [Related]
11. What's new in the treatment of viral respiratory infections in children. Part II. Chonmaitree T; Truant AL Tex Med; 1985 Feb; 81(2):43-4. PubMed ID: 3885462 [No Abstract] [Full Text] [Related]
12. Antiviral effects of cyclosporine A in neonatal mice with rotavirus-induced diarrhea. Shen Z; Tian Z; He H; Zhang J; Li J; Wu Y J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):11-7. PubMed ID: 25061717 [TBL] [Abstract][Full Text] [Related]
13. Efficacy, toxicology and clinical applications of ribavirin against virulent RNA viral infections. Canonico PG Antiviral Res; 1985; Suppl 1():75-81. PubMed ID: 2867737 [No Abstract] [Full Text] [Related]
14. Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin. Koff WC; Pratt RD; Elm JL; Venkateshan CN; Halstead SB Antimicrob Agents Chemother; 1983 Jul; 24(1):134-6. PubMed ID: 6684897 [TBL] [Abstract][Full Text] [Related]
15. Ribavirin: efficacy in the treatment of murine autoimmune disease. Klassen LW; Budman DR; Williams GW; Steinberg AD; Gerber NL Science; 1977 Feb; 195(4280):787-9. PubMed ID: 299957 [TBL] [Abstract][Full Text] [Related]
16. Ribavirin: a clinical overview. Fernandez H; Banks G; Smith R Eur J Epidemiol; 1986 Mar; 2(1):1-14. PubMed ID: 3021519 [TBL] [Abstract][Full Text] [Related]
17. Gastroenteritis in suckling mice caused by human rotavirus can be prevented with egg yolk immunoglobulin (IgY) and treated with a protein-bound polysaccharide preparation (PSK). Ebina T; Tsukada K; Umezu K; Nose M; Tsuda K; Hatta H; Kim M; Yamamoto T Microbiol Immunol; 1990; 34(7):617-29. PubMed ID: 2176268 [TBL] [Abstract][Full Text] [Related]
18. Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response. Klassen LW; Williams GW; Reinertsen JL; Gerber NL; Steinberg AD Arthritis Rheum; 1979 Feb; 22(2):145-54. PubMed ID: 33680 [TBL] [Abstract][Full Text] [Related]
19. Antiviral, immunosuppressive and antitumour effects of ribavirin. Potter CW; Phair JP; Vodinelich L; Fenton R; Jennings R Nature; 1976 Feb; 259(5543):496-7. PubMed ID: 1256547 [No Abstract] [Full Text] [Related]
20. Therapeutic effects of small-particle aerosols of ribavirin on parainfluenza (sendai) virus infections of mice. Larson EW; Stephen EL; Walker JS Antimicrob Agents Chemother; 1976 Oct; 10(4):770-2. PubMed ID: 185954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]